Articles with public access mandates - Dr Jyoti NangaliaLearn more
Not available anywhere: 6
Lineage tracing of human development through somatic mutations
M Spencer Chapman, AM Ranzoni, B Myers, N Williams, THH Coorens, ...
Nature 595 (7865), 85-90, 2021
Mandates: Cancer Research UK, UK Medical Research Council, Wellcome Trust, European …
Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms
AV Jones, D Ward, M Lyon, W Leung, A Callaway, A Chase, CL Dent, ...
Leukemia research 39 (1), 82-87, 2015
Mandates: Blood Cancer UK
Genome sequencing during a patient’s journey through cancer
J Nangalia, PJ Campbell
New England Journal of Medicine 381 (22), 2145-2156, 2019
Mandates: Cancer Research UK, UK Medical Research Council
Unmet clinical needs in the management of CALR-mutated essential thrombocythaemia: a consensus-based proposal from the European LeukemiaNet
A Alvarez-Larrán, E Sant'Antonio, C Harrison, JJ Kiladjian, ...
The Lancet Haematology 8 (9), e658-e665, 2021
Mandates: Cancer Research UK, Wellcome Trust
Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice
J Lee, AL Godfrey, J Nangalia
Blood Reviews 42, 100708, 2020
Mandates: Cancer Research UK, UK Medical Research Council, Wellcome Trust
Reconstructing phylogenetic trees from genome-wide somatic mutations in clonal samples
THH Coorens, M Spencer Chapman, N Williams, I Martincorena, ...
Nature Protocols, 1-21, 2024
Mandates: European Molecular Biology Laboratory, Cancer Research UK, Wellcome Trust
Available somewhere: 53
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
J Nangalia, CE Massie, EJ Baxter, FL Nice, G Gundem, DC Wedge, ...
New England Journal of Medicine 369 (25), 2391-2405, 2013
Mandates: Research Foundation (Flanders), Canadian Institutes of Health Research …
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Effect of mutation order on myeloproliferative neoplasms
CA Ortmann, DG Kent, J Nangalia, Y Silber, DC Wedge, J Grinfeld, ...
New England Journal of Medicine 372 (7), 601-612, 2015
Mandates: Canadian Institutes of Health Research, German Research Foundation, Blood …
Classification and personalized prognosis in myeloproliferative neoplasms
J Grinfeld, J Nangalia, EJ Baxter, DC Wedge, N Angelopoulos, R Cantrill, ...
New England Journal of Medicine 379 (15), 1416-1430, 2018
Mandates: US National Institutes of Health, Blood Cancer UK, Cancer Research UK, UK …
The mutational landscape of normal human endometrial epithelium
L Moore, D Leongamornlert, THH Coorens, MA Sanders, P Ellis, ...
Nature 580 (7805), 640-646, 2020
Mandates: Swiss National Science Foundation, Netherlands Organisation for Scientific …
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
YS Ju, LB Alexandrov, M Gerstung, I Martincorena, S Nik-Zainal, ...
elife 3, e02935, 2014
Mandates: US National Institutes of Health, National Institute of Health and Medical …
Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial
RA Mesa, AM Vannucchi, A Mead, M Egyed, A Szoke, A Suvorov, ...
The Lancet Haematology 4 (5), e225-e236, 2017
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Clonal dynamics of haematopoiesis across the human lifespan
E Mitchell, M Spencer Chapman, N Williams, KJ Dawson, N Mende, ...
Nature 606 (7913), 343-350, 2022
Mandates: German Research Foundation, UK Biotechnology and Biological Sciences …
Extensive heterogeneity in somatic mutation and selection in the human bladder
ARJ Lawson, F Abascal, THH Coorens, Y Hooks, L O’Neill, C Latimer, ...
Science 370 (6512), 75-82, 2020
Mandates: Cancer Research UK, National Institute for Health Research, UK, Wellcome …
The longitudinal dynamics and natural history of clonal haematopoiesis
MA Fabre, JG de Almeida, E Fiorillo, E Mitchell, A Damaskou, J Rak, ...
Nature 606 (7913), 335-342, 2022
Mandates: US National Institutes of Health, Blood Cancer UK, Cancer Research UK, UK …
Life histories of myeloproliferative neoplasms inferred from phylogenies
N Williams, J Lee, E Mitchell, L Moore, EJ Baxter, J Hewinson, KJ Dawson, ...
Nature 602 (7895), 162-168, 2022
Mandates: Blood Cancer UK, Cancer Research UK, UK Medical Research Council, Wellcome Trust
Myeloproliferative neoplasms: from origins to outcomes
J Nangalia, AR Green
Hematology 2014, the American Society of Hematology Education Program Book …, 2017
Mandates: Blood Cancer UK, Cancer Research UK, UK Medical Research Council, National …
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms
W Tapper, AV Jones, R Kralovics, AS Harutyunyan, K Zoi, W Leung, ...
Nature communications 6 (1), 6691, 2015
Mandates: US National Institutes of Health, Austrian Science Fund, Cancer Research UK …
A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline
M McMullin, C Harrison, S Ali, C Cargo, F Chen, J Ewing, M Garg, ...
British journal of haematology 184 (2), 2018
Mandates: Cancer Research UK, UK Medical Research Council
Publication and funding information is determined automatically by a computer program